Literature DB >> 9392719

Decreasing polypharmacy in clients most at risk.

B A Jones1.   

Abstract

Approximately one third of all drugs prescribed in the United States are considered unnecessary. Polypharmacy, the unnecessary, excessive use of prescription and over-the-counter medications, increases clients' risk for adverse drug reactions and drug-drug interactions. Reducing the incidence of polypharmacy is a health protection goal of Healthy People 2000. Older clients, particularly older women living independently in the community, are at highest risk for polypharmacy caused by age-related changes in pharmacokinetics and pharmacodynamics, the presence of comorbidities requiring pharmacologic management, and high rates of unintentional noncompliance with their therapeutic regimen. Health providers may contribute to polypharmacy directly by excessive or inappropriate prescribing practices or indirectly through their inability to resist client's demands for pharmacologic interventions. Strategies to prevent and detect polypharmacy are suggested to reduce its incidence and the severity of its consequences.

Entities:  

Mesh:

Year:  1997        PMID: 9392719     DOI: 10.1097/00044067-199711000-00014

Source DB:  PubMed          Journal:  AACN Clin Issues        ISSN: 1079-0713


  9 in total

Review 1.  STEMI and heart failure in the elderly: role of adverse remodeling.

Authors:  Anwar Jelani; Bodh I Jugdutt
Journal:  Heart Fail Rev       Date:  2010-09       Impact factor: 4.214

2.  Drug treatment in the elderly: an intervention in primary care to enhance prescription quality and quality of life.

Authors:  Inger Nordin Olsson; Rebecka Runnamo; Peter Engfeldt
Journal:  Scand J Prim Health Care       Date:  2011-12-18       Impact factor: 2.581

Review 3.  Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.

Authors:  Joanne Reeve; Michelle Maden; Ruaraidh Hill; Amadea Turk; Kamal Mahtani; Geoff Wong; Dan Lasserson; Janet Krska; Dee Mangin; Richard Byng; Emma Wallace; Ed Ranson
Journal:  Health Technol Assess       Date:  2022-07       Impact factor: 4.106

Review 4.  Clinical effectiveness of telmisartan alone or in combination therapy for controlling blood pressure and vascular risk in the elderly.

Authors:  Bodh I Jugdutt
Journal:  Clin Interv Aging       Date:  2010-12-03       Impact factor: 4.458

5.  Medication quality and quality of life in the elderly, a cohort study.

Authors:  Inger Nordin Olsson; Rebecka Runnamo; Peter Engfeldt
Journal:  Health Qual Life Outcomes       Date:  2011-11-03       Impact factor: 3.186

6.  Antioxidant Supplementation: A Linchpin in Radiation-Induced Enteritis.

Authors:  Mumtaz Anwar; Shabeer Ahmad; Reyhan Akhtar; Akhtar Mahmood; Safrun Mahmood
Journal:  Technol Cancer Res Treat       Date:  2017-05-22

7.  Development and Validation of 'Prediction of Adverse Drug Reactions in Older Inpatients (PADROI)' Risk Assessment Tool.

Authors:  Tadele Mekuriya Yadesa; Freddy Eric Kitutu; Robert Tamukong; Paul E Alele
Journal:  Clin Interv Aging       Date:  2022-02-25       Impact factor: 4.458

8.  Polypharmacy: misleading, but manageable.

Authors:  Reamer L Bushardt; Emily B Massey; Temple W Simpson; Jane C Ariail; Kit N Simpson
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

9.  Prevalence and predictors of polypharmacy among Korean elderly.

Authors:  Hong-Ah Kim; Ju-Young Shin; Mi-Hee Kim; Byung-Joo Park
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.